Loading…

Association of TNF-α promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-α and leptin levels in Indian adult women

► Tumour necrosis factor alpha involved in the pathogenesis of metabolic syndrome. ► Impact of the G-308A TNF-α variant on components of the metabolic syndrome. ► TNF-α mutant allele associated with most of the metabolic risk factors. ► TNFα gene associated with components of metabolic syndrome. ► T...

Full description

Saved in:
Bibliographic Details
Published in:Cytokine (Philadelphia, Pa.) Pa.), 2012-01, Vol.57 (1), p.32-36
Main Authors: Gupta, Vani, Gupta, Abhishek, Jafar, Tabrez, Gupta, Vandana, Agrawal, Suraksha, Srivastava, Nidhi, Kumar, Sandeep, Singh, Arun K., Natu, S.M., Agarwal, C.G., Agarwal, G.G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:► Tumour necrosis factor alpha involved in the pathogenesis of metabolic syndrome. ► Impact of the G-308A TNF-α variant on components of the metabolic syndrome. ► TNF-α mutant allele associated with most of the metabolic risk factors. ► TNFα gene associated with components of metabolic syndrome. ► TNFα gene is not associated with Insulin resistance and hyperglycemia. Tumour necrosis factor alpha is a multifunctional proinflammatory cytokine involved in the pathogenesis of metabolic syndrome, insulin resistance, and obesity. Aim of this study is to investigate in a North Indian female population the impact of the G-308A TNF-α variant on various components of the metabolic syndrome, Insulin Resistance, serum TNF-α and Leptin levels. The G-308A TNF-α polymorphism has been studied in 269 females with metabolic syndrome (NCEP ATP III criteria) (age 31.91±6.05) and 272 healthy females without metabolic syndrome (age 30.96±7.01). The G-308A variant was detected by PCR amplification and Nco-1 digestion. Homozygous mutant genotype (AA) (p=
ISSN:1043-4666
1096-0023
DOI:10.1016/j.cyto.2011.04.012